CETACAINE SPRAY 2 %
TETRACAINE HYDROCHLORIDE : 2 % BENZOCAINE : 14 % BUTAMBEN : 2 % · DIN 02028840 · CETYLITE INDUSTRIES INC.
Health Canada status: DORMANT
What is CETACAINE SPRAY?
CETACAINE SPRAY 2 % contains TETRACAINE HYDROCHLORIDE : 2 % BENZOCAINE : 14 % BUTAMBEN : 2 %. It is listed in the Health Canada Drug Product Database under DIN 02028840, held by CETYLITE INDUSTRIES INC., supplied as AEROSOL for TOPICAL administration. Health Canada currently lists it as dormant, status dated 13-Jun-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02028840 |
|---|---|
| Brand name | CETACAINE SPRAY |
| Generic / active ingredient | TETRACAINE HYDROCHLORIDE : 2 % BENZOCAINE : 14 % BUTAMBEN : 2 % |
| Manufacturer | CETYLITE INDUSTRIES INC. |
| Strength | 2 % |
| Dosage form | AEROSOL |
| Route of administration | TOPICAL |
| Schedule | Ethical |
| ATC code | D04AB30 TOPICAL ANESTHETICS, COMBINATIONS |
| AHFS class | 84:08.00 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 13-Jun-2017 |
| Original market date | 1994-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D04AB30 TOPICAL ANESTHETICS, COMBINATIONS. 2 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ONE TOUCH TOPICAL ANESTHETIC GEL | 18 % | GEL | ABJ CUSTOM PACKAGING | MARKETED | DIN 02230958 |
| ZAP TOPICAL ANESTHETIC GEL | 18 % | GEL | GERMIPHENE CORPORATION | MARKETED | DIN 01930699 |
| BURNCARE KIT | 2.4 % | SPRAY | AVACARE, DIVISION OF JEUNIQUE INTERNATIONAL INC. | CANCELLED POST MARKET | DIN 00639818 |
| DERMACAINE-R | 18 % | CREAM | INNOVATECH INC | CANCELLED (UNRETURNED ANNUAL) | DIN 02344971 |
| ZAP LIQUID | 2 % | LIQUID | GERMIPHENE CORPORATION | CANCELLED POST MARKET | DIN 00443786 |
| ZAP TOPICAL ANESTHETIC SPRAY | 18 % | SPRAY | GERMIPHENE CORPORATION | CANCELLED POST MARKET | DIN 02240984 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.